Aims Patients with cardiac disease are considered high risk for poor outcomes following
hospitalization with COVID-19. The primary aim of this study was to evaluate heterogeneity in …

Genetic factors appear to be important in the restenotic process after percutaneous coronary
intervention (PCI), as well as in inflammation, a pivotal factor in restenosis. TNFα, a key …

… PS Monraats and WRP Agema were supported by grant 99.210 from the Netherlands Heart
Foundation and a grant from the Interuniversity Cardiology Institute of the Netherlands (ICIN)…

Aims To document the practice of interventional cardiology and the clinical restenosis rate,
as well as the risk factors for clinical restenosis in an unselected population of patients in …

Objective: Restenosis is the main drawback of percutaneous coronary intervention (PCI).
Inherited factors may explain part of the risk of restenosis. Recently, the vitamin D receptor (…

Restenosis is still the main drawback of percutaneous transluminal coronary angioplasty (PTCA).
It is thought to be a multifactorial process where recoil of the vessel, neointimal …

OBJECTIVE—Patients with metabolic syndrome have increased risk of cardiovascular events.
The number of patients with metabolic syndrome is rapidly increasing, and these patients …

OBJECTIVE: Inflammatory factors are thought to play a regulatory role in restenosis. Interleukin-10
(IL10) is an important anti-inflammatory cytokine with anti-atherogenic potentials. The …

Genetic factors appear to be important in the process of restenosis after percutaneous coronary
intervention (PCI), as well as in inflammation, a pivotal factor in restenosis. An important …

Objectives The renin–angiotensin system (RAS) is thought to play a major role in the
pathophysiology of de-novo restenotic lesions and in-stent restenosis after percutaneous coronary …